Progress of Mynosys Cellular Devices’ Zepto

John Hendrick, president and CEO of Mynosys Cellular Devices, reported strong progress for Zepto, a disposable capsulotomy device. The company completed US clinical trials and submitted a request for 510(k) notification in March. Hendrick also said a trial launch in Germany and India demonstrated strong demand for the product. Mynosys received 510(k) notification in June.